Возраст домена | 14 лет |
Дата окончания | Истек срок регистрации |
PR | 4 |
ИКС | 20 |
Страниц в Google | 21400 |
Страниц в Яндексе | 1000 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 154433 |
Alexa Country | 58825 |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
TAP Homepage - The ASCO Post
n/a
n/a
UTF-8
64.87 КБ
1 013
8 477 симв.
7 240 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
ascopubs.org | 770 | 5 |
80 | 47319 | 16607 | |
cancernetwork.com | 675 | 5 |
0 | 121189 | 42503 | |
asco.org | 492 | 7 |
0 | 110566 | 47870 | |
onclive.com | 421 | 5 |
10 | 109592 | 21873 | |
alphamedpress.org | 243 | 6 |
40 | 176693 | 76227 | |
cancerconnect.com | 193 | n/a | 0 | 521587 | Нет данных | |
advancedderm.com | 114 | 3 |
0 | 750444 | 158303 | |
mycancergenome.org | 103 | 5 |
0 | 415039 | 377571 | |
lbbc.org | 88 | 6 |
0 | 862258 | 364128 | |
gotoper.com | 83 | 5 |
10 | 835093 | 281012 | |
nytimes.com | 1 | 9 |
0 | 119 | 30 | |
nih.gov | 1 | 8 |
0 | 113 | 65 | |
nature.com | 1 | 9 |
0 | 740 | 269 | |
mdanderson.org | 1 | 7 |
0 | 36166 | 6691 | |
clinicaltrials.gov | 1 | 8 |
375 | 10949 | 4120 | |
cancer.gov | 1 | 8 |
0 | 9304 | 4291 | |
cancerresearchuk.org | 1 | 8 |
0 | 20915 | 1294 | |
biomedcentral.com | 1 | 8 |
0 | 3615 | 3079 | |
Еще 32 сайта после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 20 Февраля 2015 ) | |
Количество ссылок на сайт | 1397 |
Количество доменов, которые ссылаются на сайт | 251 |
Количество найденных анкоров | 243 |
Исходящие (внешние) ссылки домена | 22793 |
Количество доменов, на которые ссылается сайт | 1337 |
Количество исходящих анкоров | 4008 |
Внешние ссылки главной страницы ( 4 ) | |
twitter.com/ascopost | View More |
twitter.com/ascopost | An Early Interest in Biology and People Led to a Career in #Oncology for Nina Shah, MD https://t.co/Gbb3ZWajLm… https://t.co/8Sv... |
hbside.com | <div> |
asco.org | ASCO.org |
Внутренние ссылки главной страницы ( 84 ) | |
# | - |
/about-the-asco-post/ | About The ASCO Post |
/editorial-board/ | Editorial Board |
/rights-and-permissions/ | Rights and Permissions |
/contact | Contact |
/Departments?D=FDA%20Update | FDA Update |
/Departments?D=Journal%20Spotlight | Journal Spotlight |
/Departments?D=Expert’s%20Corner | Expert's Corner |
/Departments?D=In%20the%20Clinic | In the Clinic |
/Issues/ | View By Issue |
/Departments/ | View All |
/Meetings/?m=2019+San+Antonio+Breast+Cancer+Symposium | 2019 San Antonio Breast Cancer Symposium |
/Meetings/?m=2019+ASH+Annual+Meeting+%26+Exposition | 2019 ASH Annual Meeting & Exposition |
/Meetings/?m=ESMO+Immuno-Oncology+Congress+2019 | ESMO Immuno-Oncology Congress 2019 |
/Meetings/?m=2019+Lynn+Sage+Breast+Cancer+Symposium | 2019 Lynn Sage Breast Cancer Symposium |
/Meetings/?m=CHEST+2019 | CHEST 2019 |
/calendar | Calendar |
/Meetings/ | View All |
/topics/solid-tumors/breast-cancer-highlights/ | Breast Cancer |
/topics/solid-tumors/lung-cancer-highlights/ | Lung Cancer |
/topics/solid-tumors/prostate-cancer-highlights/ | Prostate Cancer |
/topics/hematologic-malignancies/lymphoma-highlights/ | Lymphoma |
/topics/ | View All |
/videos/ | Videos |
/podcasts/ | Podcasts |
educate.ascopost.com/2018/podcasts/biomarkers-in-immunothera... | Biomarkers in Immunotherapy |
educate.ascopost.com/2018/AKI | <img> |
/Subscribe/default.aspx | Subscribe |
/topics/solid-tumors/breast-cancer/ | Breast Cancer |
/issues/december-25-2019/novel-antibody-drug-conjugate-shows... | Novel Antibody-Drug Conjugate Shows Efficacy in Women With Pretreated, Metastatic HER2-Positive Breast Cancer |
/topics/issues-in-oncology/ | Issues in Oncology |
/issues/december-25-2019/asco-s-national-cancer-opinion-surv... | ASCO’s National Cancer Opinion Survey Finds Gaps in Knowledge on Cancer Prevention and the Dangers of E-Cigarettes |
/podcasts/news-from-the-san-antonio-breast-cancer-symposium/ | News From the San Antonio Breast Cancer Symposium |
/topics/issues-in-oncology/immunotherapy/ | Immunotherapy |
/topics/hematologic-malignancies/lymphoma/ | Lymphoma |
/issues/december-25-2019/improving-the-precision-of-checkpoi... | KEYNOTE-013 and KEYNOTE-170: Improving the Precision of Checkpoint Blockade in Patients With Diffuse Large B-Cell Lymphoma |
/issues/december-25-2019/time-to-treatment-is-a-priority/ | Time to Treatment Is a Priority |
/videos/2019-san-antonio-breast-cancer-symposium/rashmi-murt... | Rashmi K. Murthy, MD, on HER2-Positive Metastatic Breast Cancer: HER2CLIMB Trial of Tucatinib, Capecitabine, and Trastuzumab |
/videos/2019-ash-annual-meeting-exposition/patrick-brown-on-... | Patrick A. Brown, MD, on B-Cell ALL in Children, Adolescents, and Young Adults: Blinatumomab vs Chemotherapy |
/topics/hematologic-malignancies/leukemia/ | Leukemia |
/videos/2019-san-antonio-breast-cancer-symposium/ian-krop-on... | Ian E. Krop, MD, PhD, on Trastuzumab Deruxtecan for Patients With Previously Treated, HER2-Positive Metastatic Breast Cancer |
/videos/2019-ash-annual-meeting-exposition/andrew-wei-on-the... | Andrew H. Wei, MBBS, PhD, on AML: Results From the QUAZAR Trial on Oral Azacitidine |
/videos/2019-san-antonio-breast-cancer-symposium/hope-rugo-o... | Hope S. Rugo, MD, on HER2-Positive Metastatic Breast Cancer: SOPHIA Trial of Chemotherapy Plus Margetuximab or Trastuzumab |
/news/december-2019/atezolizumab-for-pediatric-and-young-adu... | Atezolizumab for Pediatric and Young Adult Patients With Previously Treated Solid Tumors or Lymphomas |
/news/december-2019/car-t-cell-therapy-shows-activity-reduce... | ASH 2019: CAR T-Cell Therapy Shows Activity, Reduces Health-Care Utilization in Older Patients With DLBCL |
/news/december-2019/breast-cancer-incidence-with-estrogenpro... | Breast Cancer Incidence With Estrogen/Progestin vs Estrogen Alone in Postmenopausal Women |
/news/december-2019/oral-vs-intravenous-paclitaxel-for-patie... | SABCS 2019: Oral vs Intravenous Paclitaxel for Patients With Metastatic Breast Cancer |
/news/december-2019/postoperative-s-1-plus-endocrine-therapy... | Postoperative S-1 Plus Endocrine Therapy for HR-Positive, HER2-Negative Breast Cancer |
/News/ | View More |
/issues/october-10-2019/reflecting-on-my-first-national-pres... | Larry Leichman: Reflecting on My First National Presentation |
/issues/october-10-2019/younger-fit-patients-with-cll-goal-r... | Jennifer Brown: Treatment Goals for Younger, Fit Patients With CLL |
/issues/october-10-2019/multimodal-therapy-for-high-risk-or-... | Maureen E. Roberts: Multimodal Therapy for High-Risk or Locally Advanced Endometrial Cancer |
/issues/september-25-2019/breast-cancer-and-health-care-chal... | Quyen D. Chu: Health-Care Challenges of Women in Poverty |
/issues/september-25-2019/tumor-vulnerability-with-olaparib-... | Brian M. Wolpin: Maintenance Olaparib in Germline BRCA-Mutated Pancreatic Cancer |
/Departments?D=Perspectives | View More |
/videos/esmo-2019-congress/suresh-ramalingam-on-the-flaura-t... | Suresh S. Ramalingam, MD, on Osimertinib vs Comparator EGFR TKI in EGFR-Mutated NSCLC: The FLAURA Trial |
/topics/solid-tumors/lung-cancer/ | Lung Cancer |
/news/december-2019/factors-associated-with-prolonged-grief-... | Factors Associated With Prolonged Grief Symptom Levels in Parents of Children Who Have Died of Cancer |
/News/60375 | Impact of Genes on Total Number and Type of Nevi |
/videos/2019-san-antonio-breast-cancer-symposium/belinda-kin... | Belinda Kingston, MB ChB, on the Genomic Landscape of Breast Cancer Based on ctDNA Analysis |
/topics/issues-in-oncology/genomicsgenetics/ | Genomics/Genetics |
/topics/issues-in-oncology/geriatric-oncology/ | Geriatric Oncology |
/topics/solid-tumors/prostate-cancer/ | Prostate Cancer |
/news/december-2019/pembrolizumab-in-refractory-metastatic-c... | Pembrolizumab in Refractory Metastatic Castration-Resistant Prostate Cancer |
/News/60377 | Gemcitabine/Eribulin in Cisplatin-Ineligible Metastatic Urothelial Carcinoma |
/topics/solid-tumors/head-and-neck-cancer/ | Head and Neck Cancer |
/topics/supportive-care/integrative-oncology/ | Integrative Oncology |
/topics/supportive-care/symptom-management/ | Symptom Management |
/news/december-2019/acupuncture-may-reduce-radiation-induced... | Acupuncture May Reduce Radiation-Induced Dry Mouth for Patients With Head and Neck Cancer |
/News/60374 | Deintensified Chemoradiotherapy for HPV-Associated Oropharyngeal Squamous Cell Carcinoma |
/issues/december-10-2018/management-of-her2-positive-breast-... | Management of HER2-Positive Breast Cancer: Business as Usual? |
/issues/november-25-2018/the-abscopal-effect-a-reemerging-fi... | The Abscopal Effect: A Reemerging Field of Interest |
/most-read-stories/ | View More |
/videos/esmo-2019-congress/mansoor-mirza-and-robert-coleman-... | Mansoor R. Mirza, MD, and Robert L. Coleman, MD, on Integrating Velaparib With Chemotherapy and Maintenance Therapy in Gynecolog... |
/videos/2019-san-antonio-breast-cancer-symposium/nicholas-tu... | Nicholas C. Turner, MD, PhD, on ctDNA Testing to Direct Targeted Therapies in Advanced Breast Cancer |
/videos/2019-san-antonio-breast-cancer-symposium/nadine-tung... | Nadine M. Tung, MD, on HER2-Negative Breast Cancer: INFORM Trial of Cisplatin vs Doxorubicin/Cyclophosphamide |
/most-viewed-videos/ | View More |
/Trap/Bots.aspx nofollow | Bots not welcome here |
/Editorial-Board/ | Editorial Board |
/Advertising/ | Advertising |
/Disclosures/ | Disclosures |
/Contact/ | Contact |
/Privacy/ | Privacy Policy |
/Disclaimer/ | Disclaimer |
Domain Name: ASCOPOST.COM
Registry Domain ID: 1572823707_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2018-10-20T15:41:45Z
Creation Date: 2009-10-19T19:38:18Z
Registrar Registration Expiration Date: 2019-10-19T19:38:18Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: +1.4806242505
Domain Status: clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited http://www.icann.org/epp#clientUpdateProhibited
Domain Status: clientRenewProhibited http://www.icann.org/epp#clientRenewProhibited
Domain Status: clientDeleteProhibited http://www.icann.org/epp#clientDeleteProhibited
Registry Registrant ID: Not Available From Registry
Registrant Name: Registration Private
Registrant Organization: Domains By Proxy, LLC
Registrant Street: DomainsByProxy.com
Registrant Street: 14455 N. Hayden Road
Registrant City: Scottsdale
Registrant State/Province: Arizona
Registrant Postal Code: 85260
Registrant Country: US
Registrant Phone: +1.4806242599
Registrant Phone Ext:
Registrant Fax: +1.4806242598
Registrant Fax Ext:
Registrant Email: ASCOPOST.COM@domainsbyproxy.com
Registry Admin ID: Not Available From Registry
Admin Name: Registration Private
Admin Organization: Domains By Proxy, LLC
Admin Street: DomainsByProxy.com
Admin Street: 14455 N. Hayden Road
Admin City: Scottsdale
Admin State/Province: Arizona
Admin Postal Code: 85260
Admin Country: US
Admin Phone: +1.4806242599
Admin Phone Ext:
Admin Fax: +1.4806242598
Admin Fax Ext:
Admin Email: ASCOPOST.COM@domainsbyproxy.com
Registry Tech ID: Not Available From Registry
Tech Name: Registration Private
Tech Organization: Domains By Proxy, LLC
Tech Street: DomainsByProxy.com
Tech Street: 14455 N. Hayden Road
Tech City: Scottsdale
Tech State/Province: Arizona
Tech Postal Code: 85260
Tech Country: US
Tech Phone: +1.4806242599
Tech Phone Ext:
Tech Fax: +1.4806242598
Tech Fax Ext:
Tech Email: ASCOPOST.COM@domainsbyproxy.com
Name Server: NS31.DOMAINCONTROL.COM
Name Server: NS32.DOMAINCONTROL.COM
>>> Last update of WHOIS database: 2019-01-31T03:00:00Z <<<
For more information on Whois status codes, please visit https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-en
# robots.txt for Umbraco
User-agent: *
Disallow: /aspnet_client/
Disallow: /Trap/Bots.aspx
Disallow: /bin/
Disallow: /config/
Disallow: /data/
Disallow: /install/
Disallow: /masterpages/
Disallow: /python/
Disallow: /umbraco/
Disallow: /umbraco_client/
Disallow: /usercontrols/
Disallow: /xslt/
Disallow: /*.axd
Disallow: /ScriptResource.axd
Disallow: /WebResource.axd
Allow: /css/
Allow: /js/
Allow: /scripts/
Sitemap: http://www.ascopost.com/sitemap/
Британия - Ливерпуль - 213.219.33.18
Telecitygroup International Limited
Telecitygroup International Limited
HTTP/1.1 200 OK
Cache-Control: private
Content-Length: 66429
Content-Type: text/html; charset=utf-8
Set-Cookie: ASP.NET_SessionId=xemfmi0nqxn3qu1m2bhipfuy; path=/; HttpOnly
Set-Cookie: TAPUser=11feff44-b7f1-433f-8d46-e0bbac97cdd0; expires=Fri, 01-Jan-2021 19:27:16 GMT; path=/
Request-Context: appId=cid-v1:1b735935-26f3-42fc-ab8b-6b1f1084c3e7
X-Frame-Options: sameorigin
Date: Wed, 01 Jan 2020 19:27:19 GMT
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"